Outcomes after Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide in Patients with Primary Immunodeficiency Diseases (2020)
- Authors:
- Autor USP: ROCHA, VANDERSON GERALDO - FM
- Unidade: FM
- DOI: 10.1016/j.bbmt.2020.07.003
- Subjects: CÉLULAS-TRONCO; DOENÇA ENXERTO-HOSPEDEIRO; INFÂNCIA
- Language: Inglês
- Imprenta:
- Source:
- Título: Biology of blood and marrow transplantation
- ISSN: 1083-8791
- Volume/Número/Paginação/Ano: v. 26, n. 10, p. 1923-1929, 2020
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
FERNANDES, Juliana Folloni et al. Outcomes after Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide in Patients with Primary Immunodeficiency Diseases. Biology of blood and marrow transplantation, v. 26, n. 10, p. 1923-1929, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.bbmt.2020.07.003. Acesso em: 01 fev. 2026. -
APA
Fernandes, J. F., Nichele, S., Arcuri, L. J., Ribeiro, L., Zamperlini-Netto, G., Loth, G., et al. (2020). Outcomes after Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide in Patients with Primary Immunodeficiency Diseases. Biology of blood and marrow transplantation, 26( 10), 1923-1929. doi:10.1016/j.bbmt.2020.07.003 -
NLM
Fernandes JF, Nichele S, Arcuri LJ, Ribeiro L, Zamperlini-Netto G, Loth G, Rodrigues ALM, Kuwahara C, Koliski A, Rocha VG. Outcomes after Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide in Patients with Primary Immunodeficiency Diseases [Internet]. Biology of blood and marrow transplantation. 2020 ; 26( 10): 1923-1929.[citado 2026 fev. 01 ] Available from: https://doi.org/10.1016/j.bbmt.2020.07.003 -
Vancouver
Fernandes JF, Nichele S, Arcuri LJ, Ribeiro L, Zamperlini-Netto G, Loth G, Rodrigues ALM, Kuwahara C, Koliski A, Rocha VG. Outcomes after Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide in Patients with Primary Immunodeficiency Diseases [Internet]. Biology of blood and marrow transplantation. 2020 ; 26( 10): 1923-1929.[citado 2026 fev. 01 ] Available from: https://doi.org/10.1016/j.bbmt.2020.07.003 - Comparison of characteristics and laboratory tests of COVID-19 hematological patients from France and Brazil during the pre-vaccination period: identification of prognostic profiles for survival
- Outcomes of subsequent neoplasms after umbilical cord blood transplantation in Europe
- A novel mutation in RHAG causing Rh-null phenotype in Colombia. [Editorial]
- Comparative analysis of the variability of the human leukocyte antigen peptide-binding pockets in patients with acute leukaemia
- Cord blood transplantation for adult mature lymphoid neoplasms in Europe and Japan
- Autologous, allogeneic hematopoietic cell transplantation and CAR-T/NK therapy: what is their real importance in PTCL?
- Long-term clinical outcomes in a cohort of patients with solitary plasmacytoma treated in the modern era
- Validation of a formula predictive of peripheral blood stem cell yield and successful collection in healthy allogeneic donors
- Risk factors and outcomes according to age at transplantation with an HLA-identical sibling for sickle cell disease [Carta]
- Primary refractory B-cell lymphoblastic leukemia with extramedullary disease - a distinctive response to blinatumomab and inotuzumab ozogamicin
Informações sobre o DOI: 10.1016/j.bbmt.2020.07.003 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
